- LIVE QUOTES
- LEARN
- HELP
More from Webull
Our Partners
Wall Street JournalEN
C
CVAC
Curevac B.V.
3.53
0.06+1.73%After Hours: 3.650 +0.120 +3.40%16:30 04/29 EDT
OPEN/PREV CLOSE3.470/3.470
TODAY RANGE3.470-3.755
VOL926.16K
MARKET CAP794.80M
52 WEEK RANGE2.330-5.28
AVG VOL (3M)627.38K
% TURNOVER0.41%
TURNOVER--
P/E (TTM)4.712
% RANGE8.21%
EPS(TTM)0.7492
P/E(FORWARD)-5.4788
P/B1.093
BVPS3.231
DIVIDEND--
P/S1.422
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP436.35M
SHARES OUTSTANDING225.16M
NEXT EARNINGS05/21-05/26
FREE FLOAT123.61M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
NASDAQ·04/17 14:51
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
TipRanks·04/12 00:06
CureVac N.V. Earnings Call: Financial Strength Amid Challenges
TipRanks·04/11 16:45
CureVac’s Promising Pipeline and Legal Wins Justify Buy Rating
TipRanks·04/11 03:58
CureVac Stock (CVAC) Dips Despite Promising Treatment Pipeline
TipRanks·04/11 03:54
CureVac Reports Strong 2024 Financial Results and Strategic Progress
TipRanks·04/10 20:28
CureVac Reports 2024 Financial Results and Strategic Advances
TipRanks·04/10 16:05
Prada to acquire Versace, CarMax reports mixed Q4 results: Morning Buzz
Seeking Alpha·04/10 14:53
CureVac BV reports Q4 results
TipRanks·04/10 11:40
CureVac reports Q4 revenue EUR 14.5M vs. EUR 22.6M last year
TipRanks·04/10 11:40
CureVac reaffirms expected cash runway into 2028
Benzinga·04/10 11:33
CureVac Q4 Sales €14.50M May Not Be Comparable To €6.50M Estimate
Benzinga·04/10 08:32
Earnings Scheduled For April 10, 2025
Benzinga·04/09 14:01
Insights Ahead: CureVac's Quarterly Earnings
Same Industry
Name/Symbol
Change%
Price